Last week, it was reported that Brock Lesnar had been notified of a possible USADA anti-doping violation just over a week before his return to the Octagon against Mark Hunt at UFC 200. Now, it has been reported that he failed a second drug test just days after his first reported failure.
This failed test, however, happened on July 9, the day of Lesnar’s fight in Las Vegas. The UFC announced that he had tested positive for the same drug on July 9 that he had tested positive for on June 28.
“It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed,” the UFC said in a statement.
It was later reported by multiple outlets that he had tested positive for Clomiphene, an anti-estrogen blocker. It is the same drug that Jon Jones tested positive for in the week leading up his light heavyweight title bout against Daniel Cormier.
According to sources, Brock Lesnar tested positive for Clomiphene, the same anti-estrogen blocker Jon Jones tested positive for.
— Brett Okamoto (@bokamotoESPN) July 19, 2016
Clomiphene is one of the many drugs some athletes who have recently used steroids take to avoid some of the side effects. It certainly looks like Brock Lesnar is heading down a path that will lead to his fight against Mark Hunt at UFC 200 being his last.
